Search
Denotivir
go.drugbank.com/drugs/DB21323ExperimentalThe usage of the INN stem '-vir' in the name indicates that Denotivir is a antiviral. Denotivir has a monoisotopic molecular weight of 371.05 Da.
Angiotensin II
go.drugbank.com/drugs/DB11842ApprovedInvestigationalhypotensive patients who do not adequately respond to currently available therapies. … the most common type of shock in the inpatient setting and affects up to one third of patients in the intensive care unit, the FDA determined that there is a need for treatment options for critically ill
Fruquintinib
go.drugbank.com/drugs/DB11679ApprovedInvestigationalThe first approach can be exemplified by [bevacizumab], a VEGF-A trap antibody. … anti-VEGF therapy, and, if RAS wild-type and medically appropriate, an anti-EGFR therapy.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C19 SubstratesCalaspargase pegol
go.drugbank.com/drugs/DB14730ApprovedInvestigationalAsparaginase is an important agent used to treat acute lymphoblastic leukemia (ALL) [A40270]. … Calaspargase pegol, also known as _asparlas_, is an asparagine specific enzyme which is indicated as a part of a multi-agent chemotherapy regimen for the treatment of ALL [L4890].
PA3-17
go.drugbank.com/drugs/DB18569InvestigationalPA3-17 is CD7-directed chimeric antigen receptor (CAR) T-cell therapy.
Elunonavir
go.drugbank.com/drugs/DB21518ExperimentalThe usage of the INN stem '-vir' in the name indicates that Elunonavir is a antiviral. Elunonavir has a monoisotopic molecular weight of 1155.44 Da.
Droxinavir
go.drugbank.com/drugs/DB19821ExperimentalThe usage of the INN stem '-vir' in the name indicates that Droxinavir is a antiviral. Droxinavir has a monoisotopic molecular weight of 533.39 Da.
Palinavir
go.drugbank.com/drugs/DB20083ExperimentalThe usage of the INN stem '-vir' in the name indicates that Palinavir is a antiviral. Palinavir has a monoisotopic molecular weight of 708.4 Da.
Influenza B virus B/Iowa/06/2017 antigen (MDCK cell derived, propiolactone inactivated)
go.drugbank.com/drugs/DB15508ApprovedWithdrawnVaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen
Mixtures: Flucelvax Quadrivalent (multi-dose Vial)Influenza A virus A/Nebraska/14/2019 (H1N1) antigen (MDCK cell derived, propiolactone inactivated)
go.drugbank.com/drugs/DB15707ApprovedWithdrawnVaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen
Mixtures: Flucelvax Quadrivalent (multi-dose Vial)